AzTrials
AzTrials

Reversible PulpitisNCT07300124

Outcome of Direct Pulp Capping and Partial Pulpotomy in Reversible Pulpitis

A study testing Partial Pulpotomy in Reversible Pulpitis and Direct pulp capping with MTA in people with Reversible Pulpitis and Extremely Deep Caries, run by Postgraduate Institute of Dental Sciences Rohtak at 1 site in India.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

AIM: -The aim of the study is to compare the outcome of Direct Pulp Capping and Partial Pulpotomy in mature permanent teeth with Reversible Pulpitis OBJECTIVES: - Primary Objective: to compare the difference in clinical and radiographic outcome of direct pulp capping and partial pulpotomy in mature permanent teeth… Read more about this study

Who is it for?
Ages 15 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Reversible Pulpitis, Extremely Deep Caries
What is being tested?
Partial Pulpotomy in Reversible Pulpitis and Direct pulp capping with MTA
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
138 participants
Where
1 siteIndia
Study dates
10 Dec 2025to 10 Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Patients aged 15-40 years.
  • Mature permanent mandibular molars with extremely deep caries on radiograph, giving positive response to pulp sensibility test.
  • Pulpal bleeding can be controlled within 10 minutes
  • Patients having normal periapical status with periapical index (PAI) score ≤ 2
  • Periodontally healthy teeth
  • Positive response to pulp sensibility test

Who cannot join

  • Non restorable teeth
  • Negative response to vitality testing
  • Presence of sinus tract or soft tissue swelling
  • Absence of deep carious lesions radiographically
  • Radiographic signs of internal or external root resorption
  • Patient had moderate to severe pain, but preferred root canal treatment
Show all 12Show fewer
  • Presence of sound dentin over pulp and pulp not exposed intraoperatively
  • Pulp haemorrhage could not be arrested within 10 minutes.
  • Necrotic pulp evident upon exposure
  • Pregnant women
  • Absence of antagonist teeth
  • Intake of antibiotics in last 30 days

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Dr. Pankaj Sangwan, MDS contact

9996112202

drps_1@yahoo.co.in

Dr. Prerna Yadav, PG student contact

9763276071

viks0267@gmail.com

India1 site
  • PGIDS Rohtak

    Rohtak, Haryana, 124001

    Dr. Pankaj Sangwan, MDS, 9996112202, drps_1@yahoo.co.in

    Dr. Prerna Yadav, PG student, 9763276071, viks0267@gmail.com

Other trials in India

About this study

AIM: -The aim of the study is to compare the outcome of Direct Pulp Capping and Partial Pulpotomy in mature permanent teeth with Reversible Pulpitis OBJECTIVES: - Primary Objective: to compare the difference in clinical and radiographic outcome of direct pulp capping and partial pulpotomy in mature permanent teeth with Reversible Pulpitis. Secondary objective: To evaluate and compare postoperative pain after Direct Pulp Capping and Partial Pulpotomy in teeth with Reversible Pulpitis STUDY GROUPS: - Subjects of age group 15 to 40 years will be included and divided into two groups

  1. Direct Pulp Capping in Permanent mature molars with Reversible Pulpitis
  2. Partial Pulpotomy in Permanent mature molars with Reversible Pulpitis
Read the detailed description

TITLE: Outcome of Direct Pulp Capping and Partial Pulpotomy in Reversible Pulpitis It aims to answer does outcome of direct pulp capping and partial pulpotomy differ in mature permanent teeth with extremely deep caries with reversible pulpitis. P (Population) - Mature permanent mandibular molars with extremely deep caries and clinical signs of reversible pulpitis. I (Intervention) -Direct Pulp Capping in teeth with Reversible Pulpitis. C (Comparison) -Partial Pulpotomy in teeth with Reversible Pulpitis. O (Outcome) -Assessment of clinical \& radiographic success at 6 and 12 months follow up -Assessment of pain experience at baseline, post-operatively every 24 hours for 1 week In extremely deep lesions, the dental pulp is often inflamed or at risk of microbial contamination, therefore requiring timely and precise intervention in order to preserve pulp vitality. In such cases, the removal of the superficial 2-3 mm of inflamed pulp tissue can help maintain the health of the remaining pulpal tissue. Duncan and other researchers have emphasized the importance of assessing both caries depth and pulpal status for deciding the effective treatment plan. Although numerous studies have investigated the outcomes of Direct Pulp Capping (DPC) and Partial Pulpotomy separately \& have included cases based on caries depth \& pulpal status, such as reversible pulpitis. However, there remains a notable lack of comparative clinical studies directly evaluating partial pulpotomy and direct pulp capping under standardized conditions involving extremely deep carious lesions with pulpal status as reversible pulpitis. Hence, this clinical trial aims to assess and compare the clinical and radiographic outcome of Direct Pulp Capping and Partial Pulpotomy in extremely deep caries with reversible pulpitis.

Being tested
Partial Pulpotomy in Reversible Pulpitis, Direct pulp capping with MTA
Keywords
Partial Pulpotomy, Direct pulp capping

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Partial Pulpotomy in Reversible PulpitisProcedure or surgery

    Procedure/Surgery: Outcome of Partial Pulpotomy in teeth with clinical signs indicative of Reversible Pulpitis with extremely deep caries.

    After caries removal and pulp exposure , 2-3 mm of pulp tissue will be amputated and the pulpal wound irrigated with 3% NaOCl. Bleeding will be controlled by placing a cotton pellet soaked in 3% NaOCl over the pulpal wound for 2-3 minutes, repeated if required. This will be followed by capping with a 2-3 mm layer of MTA in both the groups. A layer of RMGIC will then be placed over the MTA, and the tooth will be permanently restored with composite resin.

  • Direct pulp capping with MTAProcedure or surgery

    Outcome of direct pulp capping in teeth with clinical signs indicative of reversible pulpitis.

    After caries removal and pulp exposure pulpal wound will be irrigated with 3% NaOCl, and bleeding will be controlled by placing a cotton pellet soaked with 3% NaOCl over the pulpal wound for 2 to 3 minutes and will be repeated if required. Followed by capping with MTA, a layer of RMGIC will be placed over the MTA. Then the tooth will be permanently restored with composite resin.

Study groups in NCT07300124
Study groupRoleWhat they receive
Direct Pulp Capping in Reversible PulpitisExperimentalDirect Pulp Capping will be performed on carious pulp exposure after establishing a clinical diagnosis of symptomatic reversible pulpitis based on history of pain exacerbated by cold stimuli and subsides on removal of stimuli compared to normal teeth and which is reproducible using cold testing.
Receives: Procedure: Direct pulp capping with MTA
Partial Pulpotomy in Reversible PulpitisActive comparatorPartial Pulpotomy will be performed on carious pulp exposure after establishing a clinical diagnosis of symptomatic reversible pulpitis based on history of pain exacerbated by cold stimuli and subsides on removal of stimuli compared to normal teeth and which is reproducible using cold testing.
Receives: Procedure: Partial Pulpotomy in Reversible Pulpitis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Success rate at 1 year

    Criteria for success:-

    Clinical:

    1. Absence of signs and symptoms of spontaneous pain or pain on stimulus and discomfort except for the first few days after treatment.
    2. No tenderness to palpation or percussion and the tooth is functional.
    3. Normal mobility and probing pocket depth.
    4. Absence of associated soft tissue swelling, sinus or fistula. Radiographic: -
    5. Absence of any periapical or interradicular radiolucency. 2. Complete radiographic healing (PAI score 1 or 2 acc. to Ostravik et al). 3. Absence of internal and external root resorption Tooth will be considered successful when all the above parameters are met.

    Measured: Baseline to 12 months

Secondary outcomes (1)
  1. Postoperative Pain

    Post Operative Pain- To assess incidence and intensity of pain postoperatively at every 24 hours till 7 days using Visual analogue Scale of 0 to 100 millimeter line. Score 0 means no pain and Score100 means maximum pain. To assess incidence and intensity of pain postoperatively at every 24 hours till 7 days using Visual analogue Scale of 0 to 100 millimeter line. Score 0 means no pain and Score 100 means maximum pain.

    Measured: Baseline and at 24 hours, Day 2, Day 3, Day 4, Day 5, Day 6 and Day 7 after the treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Dec 2025
  2. Study start10 Dec 2025 (estimated)
  3. Primary completion15 Jun 2027 (estimated)
  4. Study completion10 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
138 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07300124
Sponsor's protocol ID
Pankaj Sangwan
Status last verified
Dec 2025
First submitted
10 Dec 2025
Last updated
23 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Partial Pulpotomy in Reversible Pulpitis and Direct pulp capping with MTA in people with Reversible Pulpitis and Extremely Deep Caries, run by Postgraduate Institute of Dental Sciences Rohtak at 1 site in India.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 23 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in India. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Dr. Pankaj Sangwan, MDS (9996112202, drps_1@yahoo.co.in), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Success rate at 1 year (time frame: Baseline to 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in